 | • レポートコード：D0GIR-00755 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、前立腺がんスクリーニングの世界市場を広く調査・分析し、今後の市場展望をまとめております。前立腺がんスクリーニングの種類別市場規模（身体検査、臨床検査、画像検査、グリーソンスコア、TNMスコア、遺伝子検査、直腸指診、生検）、用途別市場規模（病院、クリニック、研究所、がん研究所、診断センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、Mdxhealth、Beckman Coulter、Almac、Mayo Clinic、Bayer、Rosetta Genomics、Genomic Health、BioméRieux、Roche Diagnostics、Thermo Fisher Scientific、Hologic、Myriad Genetics ・地域別グローバル市場分析 2015年-2020年 ・前立腺がんスクリーニングの北米市場（アメリカ、カナダ、メキシコ） ・前立腺がんスクリーニングのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・前立腺がんスクリーニングのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・前立腺がんスクリーニングの南米市場（ブラジル、アルゼンチン） ・前立腺がんスクリーニングの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：身体検査、臨床検査、画像検査、グリーソンスコア、TNMスコア、遺伝子検査、直腸指診、生検 ・用途別分析：病院、クリニック、研究所、がん研究所、診断センター、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Prostate Cancer Screening market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Prostate Cancer Screening market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Prostate Cancer Screening market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Prostate Cancer Screening market has been segmented into:
Physical Exam
Laboratory Tests
Imaging Tests
Gleason Score
TNM Score
Genetic Tests
Digital Rectal Exam
Biopsy
By Application, Prostate Cancer Screening has been segmented into:
Hospitals
Clinics
Research Labs
Cancer Institutes
Diagnostic Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Prostate Cancer Screening market presented in the report. This section sheds light on the sales growth of different regional and country-level Prostate Cancer Screening markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prostate Cancer Screening market.
The report offers in-depth assessment of the growth and other aspects of the Prostate Cancer Screening market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Prostate Cancer Screening Market Share Analysis
Prostate Cancer Screening competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prostate Cancer Screening sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prostate Cancer Screening sales, revenue and market share for each player covered in this report.
The major players covered in Prostate Cancer Screening are:
Abbott Laboratories
Mdxhealth
Beckman Coulter
Almac
Mayo Clinic
Bayer
Rosetta Genomics
Genomic Health
BioméRieux
Roche Diagnostics
Thermo Fisher Scientific
Hologic
Myriad Genetics
Table of Contents
1 Prostate Cancer Screening Market Overview
1.1 Product Overview and Scope of Prostate Cancer Screening
1.2 Classification of Prostate Cancer Screening by Type
1.2.1 Global Prostate Cancer Screening Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Prostate Cancer Screening Revenue Market Share by Type in 2019
1.2.3 Physical Exam
1.2.4 Laboratory Tests
1.2.5 Imaging Tests
1.2.6 Gleason Score
1.2.7 TNM Score
1.2.8 Genetic Tests
1.2.9 Digital Rectal Exam
1.2.10 Biopsy
1.3 Global Prostate Cancer Screening Market by Application
1.3.1 Overview: Global Prostate Cancer Screening Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Labs
1.3.5 Cancer Institutes
1.3.6 Diagnostic Centers
1.3.7 Others
1.4 Global Prostate Cancer Screening Market by Regions
1.4.1 Global Prostate Cancer Screening Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Prostate Cancer Screening (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Prostate Cancer Screening Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Prostate Cancer Screening Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostate Cancer Screening Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Prostate Cancer Screening Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostate Cancer Screening Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Prostate Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mdxhealth
2.2.1 Mdxhealth Details
2.2.2 Mdxhealth Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mdxhealth SWOT Analysis
2.2.4 Mdxhealth Product and Services
2.2.5 Mdxhealth Prostate Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.3 Beckman Coulter
2.3.1 Beckman Coulter Details
2.3.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Beckman Coulter SWOT Analysis
2.3.4 Beckman Coulter Product and Services
2.3.5 Beckman Coulter Prostate Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.4 Almac
2.4.1 Almac Details
2.4.2 Almac Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Almac SWOT Analysis
2.4.4 Almac Product and Services
2.4.5 Almac Prostate Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mayo Clinic
2.5.1 Mayo Clinic Details
2.5.2 Mayo Clinic Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Mayo Clinic SWOT Analysis
2.5.4 Mayo Clinic Product and Services
2.5.5 Mayo Clinic Prostate Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bayer SWOT Analysis
2.6.4 Bayer Product and Services
2.6.5 Bayer Prostate Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.7 Rosetta Genomics
2.7.1 Rosetta Genomics Details
2.7.2 Rosetta Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Rosetta Genomics SWOT Analysis
2.7.4 Rosetta Genomics Product and Services
2.7.5 Rosetta Genomics Prostate Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.8 Genomic Health
2.8.1 Genomic Health Details
2.8.2 Genomic Health Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Genomic Health SWOT Analysis
2.8.4 Genomic Health Product and Services
2.8.5 Genomic Health Prostate Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.9 BioméRieux
2.9.1 BioméRieux Details
2.9.2 BioméRieux Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BioméRieux SWOT Analysis
2.9.4 BioméRieux Product and Services
2.9.5 BioméRieux Prostate Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.10 Roche Diagnostics
2.10.1 Roche Diagnostics Details
2.10.2 Roche Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Roche Diagnostics SWOT Analysis
2.10.4 Roche Diagnostics Product and Services
2.10.5 Roche Diagnostics Prostate Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.11 Thermo Fisher Scientific
2.11.1 Thermo Fisher Scientific Details
2.11.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Thermo Fisher Scientific SWOT Analysis
2.11.4 Thermo Fisher Scientific Product and Services
2.11.5 Thermo Fisher Scientific Prostate Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.12 Hologic
2.12.1 Hologic Details
2.12.2 Hologic Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Hologic SWOT Analysis
2.12.4 Hologic Product and Services
2.12.5 Hologic Prostate Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
2.13 Myriad Genetics
2.13.1 Myriad Genetics Details
2.13.2 Myriad Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Myriad Genetics SWOT Analysis
2.13.4 Myriad Genetics Product and Services
2.13.5 Myriad Genetics Prostate Cancer Screening Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Prostate Cancer Screening Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Prostate Cancer Screening Players Market Share
3.2.2 Top 10 Prostate Cancer Screening Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Prostate Cancer Screening Revenue and Market Share by Regions
4.2 North America Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
4.3 Europe Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
4.5 South America Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
5 North America Prostate Cancer Screening Revenue by Countries
5.1 North America Prostate Cancer Screening Revenue by Countries (2015-2020)
5.2 USA Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
5.3 Canada Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
5.4 Mexico Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
6 Europe Prostate Cancer Screening Revenue by Countries
6.1 Europe Prostate Cancer Screening Revenue by Countries (2015-2020)
6.2 Germany Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
6.3 UK Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
6.4 France Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
6.5 Russia Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
6.6 Italy Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Prostate Cancer Screening Revenue by Countries
7.1 Asia-Pacific Prostate Cancer Screening Revenue by Countries (2015-2020)
7.2 China Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
7.3 Japan Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
7.4 Korea Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
7.5 India Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
8 South America Prostate Cancer Screening Revenue by Countries
8.1 South America Prostate Cancer Screening Revenue by Countries (2015-2020)
8.2 Brazil Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
8.3 Argentina Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Prostate Cancer Screening by Countries
9.1 Middle East & Africa Prostate Cancer Screening Revenue by Countries (2015-2020)
9.2 Saudi Arabia Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
9.3 UAE Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
9.4 Egypt Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
9.5 South Africa Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Prostate Cancer Screening Revenue and Market Share by Type (2015-2020)
10.2 Global Prostate Cancer Screening Market Forecast by Type (2019-2024)
10.3 Physical Exam Revenue Growth Rate (2015-2025)
10.4 Laboratory Tests Revenue Growth Rate (2015-2025)
10.5 Imaging Tests Revenue Growth Rate (2015-2025)
10.6 Gleason Score Revenue Growth Rate (2015-2025)
10.7 TNM Score Revenue Growth Rate (2015-2025)
10.8 Genetic Tests Revenue Growth Rate (2015-2025)
10.9 Digital Rectal Exam Revenue Growth Rate (2015-2025)
10.10 Biopsy Revenue Growth Rate (2015-2025)
11 Global Prostate Cancer Screening Market Segment by Application
11.1 Global Prostate Cancer Screening Revenue Market Share by Application (2015-2020)
11.2 Prostate Cancer Screening Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Research Labs Revenue Growth (2015-2020)
11.6 Cancer Institutes Revenue Growth (2015-2020)
11.7 Diagnostic Centers Revenue Growth (2015-2020)
11.8 Others Revenue Growth (2015-2020)
12 Global Prostate Cancer Screening Market Size Forecast (2021-2025)
12.1 Global Prostate Cancer Screening Market Size Forecast (2021-2025)
12.2 Global Prostate Cancer Screening Market Forecast by Regions (2021-2025)
12.3 North America Prostate Cancer Screening Revenue Market Forecast (2021-2025)
12.4 Europe Prostate Cancer Screening Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Prostate Cancer Screening Revenue Market Forecast (2021-2025)
12.6 South America Prostate Cancer Screening Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Prostate Cancer Screening Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Prostate Cancer Screening Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Prostate Cancer Screening by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Prostate Cancer Screening Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Prostate Cancer Screening Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Prostate Cancer Screening Major Business
Table 7. Abbott Laboratories Prostate Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Prostate Cancer Screening Product and Solutions
Table 10. Abbott Laboratories Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Mdxhealth Corporate Information, Location and Competitors
Table 12. Mdxhealth Prostate Cancer Screening Major Business
Table 13. Mdxhealth Prostate Cancer Screening Total Revenue (USD Million) (2018-2019)
Table 14. Mdxhealth SWOT Analysis
Table 15. Mdxhealth Prostate Cancer Screening Product and Solutions
Table 16. Mdxhealth Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Beckman Coulter Corporate Information, Location and Competitors
Table 18. Beckman Coulter Prostate Cancer Screening Major Business
Table 19. Beckman Coulter Prostate Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 20. Beckman Coulter SWOT Analysis
Table 21. Beckman Coulter Prostate Cancer Screening Product and Solutions
Table 22. Beckman Coulter Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Almac Corporate Information, Location and Competitors
Table 24. Almac Prostate Cancer Screening Major Business
Table 25. Almac Prostate Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 26. Almac SWOT Analysis
Table 27. Almac Prostate Cancer Screening Product and Solutions
Table 28. Almac Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Mayo Clinic Corporate Information, Location and Competitors
Table 30. Mayo Clinic Prostate Cancer Screening Major Business
Table 31. Mayo Clinic Prostate Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 32. Mayo Clinic SWOT Analysis
Table 33. Mayo Clinic Prostate Cancer Screening Product and Solutions
Table 34. Mayo Clinic Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bayer Corporate Information, Location and Competitors
Table 36. Bayer Prostate Cancer Screening Major Business
Table 37. Bayer Prostate Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 38. Bayer SWOT Analysis
Table 39. Bayer Prostate Cancer Screening Product and Solutions
Table 40. Bayer Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Rosetta Genomics Corporate Information, Location and Competitors
Table 42. Rosetta Genomics Prostate Cancer Screening Major Business
Table 43. Rosetta Genomics Prostate Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 44. Rosetta Genomics SWOT Analysis
Table 45. Rosetta Genomics Prostate Cancer Screening Product and Solutions
Table 46. Rosetta Genomics Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Genomic Health Corporate Information, Location and Competitors
Table 48. Genomic Health Prostate Cancer Screening Major Business
Table 49. Genomic Health Prostate Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 50. Genomic Health SWOT Analysis
Table 51. Genomic Health Prostate Cancer Screening Product and Solutions
Table 52. Genomic Health Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. BioméRieux Corporate Information, Location and Competitors
Table 54. BioméRieux Prostate Cancer Screening Major Business
Table 55. BioméRieux Prostate Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 56. BioméRieux SWOT Analysis
Table 57. BioméRieux Prostate Cancer Screening Product and Solutions
Table 58. BioméRieux Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Roche Diagnostics Corporate Information, Location and Competitors
Table 60. Roche Diagnostics Prostate Cancer Screening Major Business
Table 61. Roche Diagnostics Prostate Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 62. Roche Diagnostics SWOT Analysis
Table 63. Roche Diagnostics Prostate Cancer Screening Product and Solutions
Table 64. Roche Diagnostics Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 66. Thermo Fisher Scientific Prostate Cancer Screening Major Business
Table 67. Thermo Fisher Scientific Prostate Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 68. Thermo Fisher Scientific SWOT Analysis
Table 69. Thermo Fisher Scientific Prostate Cancer Screening Product and Solutions
Table 70. Thermo Fisher Scientific Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Hologic Corporate Information, Location and Competitors
Table 72. Hologic Prostate Cancer Screening Major Business
Table 73. Hologic Prostate Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 74. Hologic SWOT Analysis
Table 75. Hologic Prostate Cancer Screening Product and Solutions
Table 76. Hologic Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Myriad Genetics Corporate Information, Location and Competitors
Table 78. Myriad Genetics Prostate Cancer Screening Major Business
Table 79. Myriad Genetics Prostate Cancer Screening Total Revenue (USD Million) (2017-2018)
Table 80. Myriad Genetics SWOT Analysis
Table 81. Myriad Genetics Prostate Cancer Screening Product and Solutions
Table 82. Myriad Genetics Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Prostate Cancer Screening Revenue (Million USD) by Players (2015-2020)
Table 84. Global Prostate Cancer Screening Revenue Share by Players (2015-2020)
Table 85. Global Prostate Cancer Screening Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Prostate Cancer Screening Revenue Market Share by Regions (2015-2020)
Table 87. North America Prostate Cancer Screening Revenue by Countries (2015-2020)
Table 88. North America Prostate Cancer Screening Revenue Market Share by Countries (2015-2020)
Table 89. Europe Prostate Cancer Screening Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Prostate Cancer Screening Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Prostate Cancer Screening Revenue by Countries (2015-2020)
Table 92. South America Prostate Cancer Screening Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Prostate Cancer Screening Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Prostate Cancer Screening Revenue Market Share by Countries (2015-2020)
Table 95. Global Prostate Cancer Screening Revenue (Million USD) by Type (2015-2020)
Table 96. Global Prostate Cancer Screening Revenue Share by Type (2015-2020)
Table 97. Global Prostate Cancer Screening Revenue Forecast by Type (2021-2025)
Table 98. Global Prostate Cancer Screening Revenue by Application (2015-2020)
Table 99. Global Prostate Cancer Screening Revenue Share by Application (2015-2020)
Table 100. Global Prostate Cancer Screening Revenue Forecast by Application (2021-2025)
Table 101. Global Prostate Cancer Screening Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Prostate Cancer Screening Picture
Figure 2. Global Prostate Cancer Screening Revenue Market Share by Type in 2019
Figure 3. Physical Exam Picture
Figure 4. Laboratory Tests Picture
Figure 5. Imaging Tests Picture
Figure 6. Gleason Score Picture
Figure 7. TNM Score Picture
Figure 8. Genetic Tests Picture
Figure 9. Digital Rectal Exam Picture
Figure 10. Biopsy Picture
Figure 11. Prostate Cancer Screening Revenue Market Share by Application in 2019
Figure 12. Hospitals Picture
Figure 13. Clinics Picture
Figure 14. Research Labs Picture
Figure 15. Cancer Institutes Picture
Figure 16. Diagnostic Centers Picture
Figure 17. Others Picture
Figure 18. Global Prostate Cancer Screening Revenue (USD Million) and Growth Rate (2015-2025)
Figure 19. North America Prostate Cancer Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Europe Prostate Cancer Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Asia-Pacific Prostate Cancer Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. South America Prostate Cancer Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Middle East and Africa Prostate Cancer Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 24. Global Prostate Cancer Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 25. Global Prostate Cancer Screening Revenue Share by Players in 2019
Figure 26. Global Top 5 Players Prostate Cancer Screening Revenue Market Share in 2019
Figure 27. Global Top 10 Players Prostate Cancer Screening Revenue Market Share in 2019
Figure 28. Key Players Market Share Trend
Figure 29. Global Prostate Cancer Screening Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 30. Global Prostate Cancer Screening Revenue Market Share by Regions (2015-2020)
Figure 31. Global Prostate Cancer Screening Revenue Market Share by Regions in 2018
Figure 32. North America Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 33. Europe Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 34. Asia-Pacific Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 35. South America Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 36. Middle East and Africa Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 37. North America Prostate Cancer Screening Revenue Market Share by Countries (2015-2020)
Figure 38. North America Prostate Cancer Screening Revenue Market Share by Countries in 2019
Figure 39. USA Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 40. Canada Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 41. Mexico Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 42. Europe Prostate Cancer Screening Revenue Market Share by Countries (2015-2020)
Figure 43. Europe Prostate Cancer Screening Revenue Market Share by Countries in 2019
Figure 44. Germany Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 45. UK Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 46. France Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 47. Russia Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 48. Italy Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 49. Asia-Pacific Prostate Cancer Screening Revenue Market Share by Countries (2015-2020)
Figure 50. Asia-Pacific Prostate Cancer Screening Revenue Market Share by Countries in 2019
Figure 51. China Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 52. Japan Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 53. Korea Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 54. India Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 55. Southeast Asia Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 56. South America Prostate Cancer Screening Revenue Market Share by Countries (2015-2020)
Figure 57. South America Prostate Cancer Screening Revenue Market Share by Countries in 2019
Figure 58. Brazil Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 59. Argentina Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 60. Middle East and Africa Prostate Cancer Screening Revenue Market Share by Countries (2015-2020)
Figure 61. Middle East and Africa Prostate Cancer Screening Revenue Market Share by Countries in 2019
Figure 62. Saudi Arabia Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 63. UAE Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 64. Egypt Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 65. South Africa Prostate Cancer Screening Revenue and Growth Rate (2015-2020)
Figure 66. Global Prostate Cancer Screening Revenue Share by Type (2015-2020)
Figure 67. Global Prostate Cancer Screening Revenue Share by Type in 2019
Figure 68. Global Prostate Cancer Screening Market Share Forecast by Type (2021-2025)
Figure 69. Global Physical Exam Revenue Growth Rate (2015-2020)
Figure 70. Global Laboratory Tests Revenue Growth Rate (2015-2020)
Figure 71. Global Imaging Tests Revenue Growth Rate (2015-2020)
Figure 72. Global Gleason Score Revenue Growth Rate (2015-2020)
Figure 73. Global TNM Score Revenue Growth Rate (2015-2020)
Figure 74. Global Genetic Tests Revenue Growth Rate (2015-2020)
Figure 75. Global Digital Rectal Exam Revenue Growth Rate (2015-2020)
Figure 76. Global Biopsy Revenue Growth Rate (2015-2020)
Figure 77. Global Prostate Cancer Screening Revenue Share by Application (2015-2020)
Figure 78. Global Prostate Cancer Screening Revenue Share by Application in 2019
Figure 79. Global Prostate Cancer Screening Market Share Forecast by Application (2021-2025)
Figure 80. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 81. Global Clinics Revenue Growth Rate (2015-2020)
Figure 82. Global Research Labs Revenue Growth Rate (2015-2020)
Figure 83. Global Cancer Institutes Revenue Growth Rate (2015-2020)
Figure 84. Global Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 85. Global Others Revenue Growth Rate (2015-2020)
Figure 86. Global Prostate Cancer Screening Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 87. Global Prostate Cancer Screening Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 88. Global Prostate Cancer Screening Revenue Market Share Forecast by Regions (2021-2025)
Figure 89. North America Prostate Cancer Screening Revenue Market Forecast (2021-2025)
Figure 90. Europe Prostate Cancer Screening Revenue Market Forecast (2021-2025)
Figure 91. Asia-Pacific Prostate Cancer Screening Revenue Market Forecast (2021-2025)
Figure 92. South America Prostate Cancer Screening Revenue Market Forecast (2021-2025)
Figure 93. Middle East and Africa Prostate Cancer Screening Revenue Market Forecast (2021-2025)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel
前立腺がん治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Prostate Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prostate Canc…- 前立腺がんバイオマーカーの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Prostate Cancer Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prostate Cancer Bio…
- 前立腺がん診断・治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Prostate Cancer Diagnosis and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prost…
- がん検査/スクリーニングの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Cancer Testing/Screening market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer Testing/Scree…
- 白血病スクリーニングの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Leukemia Screening market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Leukemia Screening market …